NCT04995523
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04995523
Title A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC (ARTEMIDE-01)
Acronym ARTEMIDE-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | FRA | ESP | DNK | BRA | BEL | AUS

Facility Status City State Zip Country Details
Research Site WITHDRAWN Orange California 92868 United States Details
Research Site RECRUITING Chicago Illinois 60637 United States Details
Research Site WITHDRAWN Baltimore Maryland 21201 United States Details
Research Site RECRUITING Rochester Minnesota 55905 United States Details
Research Site WITHDRAWN Houston Texas 77030 United States Details
Research Site RECRUITING Fairfax Virginia 22031 United States Details
Research Site COMPLETED Melbourne 3000 Australia Details
Research Site ACTIVE_NOT_RECRUITING Anderlecht 1070 Belgium Details
Research Site ACTIVE_NOT_RECRUITING Leuven 3000 Belgium Details
Research Site RECRUITING Florianópolis 88034-000 Brazil Details
Research Site RECRUITING Natal 59075-740 Brazil Details
Research Site RECRUITING Porto Alegre 90035903 Brazil Details
Research Site RECRUITING Rio de Janeiro 20231-050 Brazil Details
Research Site RECRUITING São Paulo 01246-000 Brazil Details
Research Site RECRUITING Chengdu 610041 China Details
Research Site ACTIVE_NOT_RECRUITING Chongqing 400030 China Details
Research Site WITHDRAWN Wuhan 430022 China Details
Research Site ACTIVE_NOT_RECRUITING Copenhagen 2100 Denmark Details
Research Site RECRUITING Dijon 21079 France Details
Research Site RECRUITING Toulouse 31059 France Details
Research Site RECRUITING Tbilisi 0112 Georgia Details
Research Site RECRUITING Kashiwa 227-8577 Japan Details
Research Site RECRUITING Niigata 951-8566 Japan Details
Research Site RECRUITING Sendai 981-0914 Japan Details
Research Site RECRUITING Tokyo 104-0045 Japan Details
Research Site RECRUITING Kuala Lumpur 59100 Malaysia Details
Research Site RECRUITING Kuching 93586 Malaysia Details
Research Site RECRUITING Chisinau MD-2025 Moldova Details
Research Site ACTIVE_NOT_RECRUITING Groningen 9713 GZ Netherlands Details
Research Site ACTIVE_NOT_RECRUITING Leiden 2333 ZA Netherlands Details
Research Site COMPLETED Utrecht 3584 CX Netherlands Details
Research Site WITHDRAWN Singapore 308433 Singapore Details
Research Site RECRUITING Seoul 03082 South Korea Details
Research Site RECRUITING Seoul 03722 South Korea Details
Research Site RECRUITING Seoul 05505 South Korea Details
Research Site ACTIVE_NOT_RECRUITING Barcelona 08035 Spain Details
Research Site ACTIVE_NOT_RECRUITING Madrid 28027 Spain Details
Research Site ACTIVE_NOT_RECRUITING Madrid 28041 Spain Details
Research Site RECRUITING Taichung 40201 Taiwan Details
Research Site RECRUITING Taichung Taiwan Details
Research Site RECRUITING Tainan 70403 Taiwan Details
Research Site WITHDRAWN Taipei 10002 Taiwan Details
Research Site RECRUITING Taipei 110 Taiwan Details
Research Site RECRUITING Bangkok 10700 Thailand Details
Research Site RECRUITING Chanthaburi 22000 Thailand Details
Research Site RECRUITING Muang 50200 Thailand Details
Research Site WITHDRAWN Leicester LE1 5WW United Kingdom Details
Research Site WITHDRAWN Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field